These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 24886204)
1. Tumor loci and their interactions on mouse chromosome 19 that contribute to testicular germ cell tumors. Zhu R; Matin A BMC Genet; 2014 May; 15():65. PubMed ID: 24886204 [TBL] [Abstract][Full Text] [Related]
2. Testicular cancer susceptibility in the 129.MOLF-Chr19 mouse strain: additive effects, gene interactions and epigenetic modifications. Youngren KK; Nadeau JH; Matin A Hum Mol Genet; 2003 Feb; 12(4):389-98. PubMed ID: 12566386 [TBL] [Abstract][Full Text] [Related]
3. Testicular germ cell tumors in mice: new ways to study a genetically complex trait. Heaney JD; Nadeau JH Methods Mol Biol; 2008; 450():211-31. PubMed ID: 18370062 [TBL] [Abstract][Full Text] [Related]
4. Testicular germ cell tumor susceptibility genes from the consomic 129.MOLF-Chr19 mouse strain. Zhu R; Ji Y; Xiao L; Matin A Mamm Genome; 2007 Aug; 18(8):584-95. PubMed ID: 17671812 [TBL] [Abstract][Full Text] [Related]
5. Deficiency of splicing factor 1 suppresses the occurrence of testicular germ cell tumors. Zhu R; Heaney J; Nadeau JH; Ali S; Matin A Cancer Res; 2010 Sep; 70(18):7264-72. PubMed ID: 20736371 [TBL] [Abstract][Full Text] [Related]
6. Genetic factors on mouse chromosome 18 affecting susceptibility to testicular germ cell tumors and permissiveness to embryonic stem cell derivation. Anderson PD; Nelson VR; Tesar PJ; Nadeau JH Cancer Res; 2009 Dec; 69(23):9112-7. PubMed ID: 19934337 [TBL] [Abstract][Full Text] [Related]
8. The role of the mouse y chromosome on susceptibility to testicular germ cell tumors. Anderson PD; Lam MY; Poirier C; Bishop CE; Nadeau JH Cancer Res; 2009 Apr; 69(8):3614-8. PubMed ID: 19351821 [TBL] [Abstract][Full Text] [Related]
9. Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. Schumacher FR; Wang Z; Skotheim RI; Koster R; Chung CC; Hildebrandt MA; Kratz CP; Bakken AC; Bishop DT; Cook MB; Erickson RL; Fosså SD; Greene MH; Jacobs KB; Kanetsky PA; Kolonel LN; Loud JT; Korde LA; Le Marchand L; Lewinger JP; Lothe RA; Pike MC; Rahman N; Rubertone MV; Schwartz SM; Siegmund KD; Skinner EC; Turnbull C; Van Den Berg DJ; Wu X; Yeager M; Nathanson KL; Chanock SJ; Cortessis VK; McGlynn KA Hum Mol Genet; 2013 Jul; 22(13):2748-53. PubMed ID: 23462292 [TBL] [Abstract][Full Text] [Related]
10. [Polymorphisms of KITLG, SPRY4, and BAK1 genes in patients with testicular germ cell tumors and individuals with infertility associated with AZFc deletion of the Y chromosome]. Nemtsova MV; Ivkin EV; Simonova OA; Rudenko VV; Chernykh VB; Mikhaylenko DS; Loran OB Mol Biol (Mosk); 2016; 50(6):960-967. PubMed ID: 28064312 [TBL] [Abstract][Full Text] [Related]
11. Prospectively Identified Incident Testicular Cancer Risk in a Familial Testicular Cancer Cohort. Pathak A; Adams CD; Loud JT; Nichols K; Stewart DR; Greene MH Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1614-21. PubMed ID: 26265202 [TBL] [Abstract][Full Text] [Related]
12. What leads from dead-end? Matin A Cell Mol Life Sci; 2007 Jun; 64(11):1317-22. PubMed ID: 17464447 [TBL] [Abstract][Full Text] [Related]
14. A mini-review of familial ovarian germ cell tumors: an additional manifestation of the familial testicular germ cell tumor syndrome. Giambartolomei C; Mueller CM; Greene MH; Korde LA Cancer Epidemiol; 2009 Jul; 33(1):31-6. PubMed ID: 19679044 [TBL] [Abstract][Full Text] [Related]
15. Enhancers and suppressors of testicular cancer susceptibility in single- and double-mutant mice. Lam MY; Youngren KK; Nadeau JH Genetics; 2004 Feb; 166(2):925-33. PubMed ID: 15020477 [TBL] [Abstract][Full Text] [Related]
16. Loss of the transmembrane but not the soluble kit ligand isoform increases testicular germ cell tumor susceptibility in mice. Heaney JD; Lam MY; Michelson MV; Nadeau JH Cancer Res; 2008 Jul; 68(13):5193-7. PubMed ID: 18593919 [TBL] [Abstract][Full Text] [Related]
17. Transgenerational epigenetic effects of the Apobec1 cytidine deaminase deficiency on testicular germ cell tumor susceptibility and embryonic viability. Nelson VR; Heaney JD; Tesar PJ; Davidson NO; Nadeau JH Proc Natl Acad Sci U S A; 2012 Oct; 109(41):E2766-73. PubMed ID: 22923694 [TBL] [Abstract][Full Text] [Related]
18. Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor. Litchfield K; Levy M; Orlando G; Loveday C; Law PJ; Migliorini G; Holroyd A; Broderick P; Karlsson R; Haugen TB; Kristiansen W; Nsengimana J; Fenwick K; Assiotis I; Kote-Jarai Z; Dunning AM; Muir K; Peto J; Eeles R; Easton DF; Dudakia D; Orr N; Pashayan N; ; ; Bishop DT; Reid A; Huddart RA; Shipley J; Grotmol T; Wiklund F; Houlston RS; Turnbull C Nat Genet; 2017 Jul; 49(7):1133-1140. PubMed ID: 28604728 [TBL] [Abstract][Full Text] [Related]
19. The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. Youngren KK; Coveney D; Peng X; Bhattacharya C; Schmidt LS; Nickerson ML; Lamb BT; Deng JM; Behringer RR; Capel B; Rubin EM; Nadeau JH; Matin A Nature; 2005 May; 435(7040):360-4. PubMed ID: 15902260 [TBL] [Abstract][Full Text] [Related]